Mechanisms of deoxyguanosine toxicity for human T and B lymphocytes.
about
Nelarabine in the treatment of refractory T-cell malignanciesPhase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia.A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine)
P2860
Mechanisms of deoxyguanosine toxicity for human T and B lymphocytes.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Mechanisms of deoxyguanosine toxicity for human T and B lymphocytes.
@en
Mechanisms of deoxyguanosine toxicity for human T and B lymphocytes.
@nl
type
label
Mechanisms of deoxyguanosine toxicity for human T and B lymphocytes.
@en
Mechanisms of deoxyguanosine toxicity for human T and B lymphocytes.
@nl
prefLabel
Mechanisms of deoxyguanosine toxicity for human T and B lymphocytes.
@en
Mechanisms of deoxyguanosine toxicity for human T and B lymphocytes.
@nl
P2093
P1476
Mechanisms of deoxyguanosine toxicity for human T and B lymphocytes.
@en
P2093
B J Zegers
G T Rijkers
J G Scharenberg
L J Spaapen
S K Wadman
P304
P407
P478
P577
1986-01-01T00:00:00Z